218 related articles for article (PubMed ID: 18245528)
21. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
22. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression.
Dadi S; Le Noir S; Payet-Bornet D; Lhermitte L; Zacarias-Cabeza J; Bergeron J; Villarèse P; Vachez E; Dik WA; Millien C; Radford I; Verhoeyen E; Cosset FL; Petit A; Ifrah N; Dombret H; Hermine O; Spicuglia S; Langerak AW; Macintyre EA; Nadel B; Ferrier P; Asnafi V
Cancer Cell; 2012 Apr; 21(4):563-76. PubMed ID: 22516263
[TBL] [Abstract][Full Text] [Related]
23. Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome.
Karrman K; Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Ehrencrona H; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Palmqvist L; Johansson B; ; ;
Genes Chromosomes Cancer; 2009 Sep; 48(9):795-805. PubMed ID: 19530250
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
Callens C; Baleydier F; Lengline E; Ben Abdelali R; Petit A; Villarese P; Cieslak A; Minard-Colin V; Rullier A; Moreau A; Baruchel A; Schmitt C; Asnafi V; Bertrand Y; Macintyre E
J Clin Oncol; 2012 Jun; 30(16):1966-73. PubMed ID: 22547598
[TBL] [Abstract][Full Text] [Related]
25. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
[TBL] [Abstract][Full Text] [Related]
26. Pattern of immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Polish pediatric acute lymphoblastic leukemia patients--implications for RQ-PCR-based assessment of minimal residual disease.
Dawidowska M; Derwich K; Szczepański T; Jółkowska J; van der Velden VH; Wachowiak J; Witt M
Leuk Res; 2006 Sep; 30(9):1119-25. PubMed ID: 16476479
[TBL] [Abstract][Full Text] [Related]
27. [Report of 18 cases lymphoblastic lymphoma].
Zhang X; Lu Z; Feng X
Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):566-8. PubMed ID: 11263338
[TBL] [Abstract][Full Text] [Related]
28. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.
Vanura K; Vrsalovic MM; Le T; Marculescu R; Kusec R; Jäger U; Nadel B
Genes Chromosomes Cancer; 2009 Aug; 48(8):725-36. PubMed ID: 19455608
[TBL] [Abstract][Full Text] [Related]
29. Precursor T-cell acute lymphoblastic leukemia in adults: age-related immunophenotypic, cytogenetic, and molecular subsets.
Onciu M; Lai R; Vega F; Bueso-Ramos C; Medeiros LJ
Am J Clin Pathol; 2002 Feb; 117(2):252-8. PubMed ID: 11863221
[TBL] [Abstract][Full Text] [Related]
30. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia.
Meijerink JP
Best Pract Res Clin Haematol; 2010 Sep; 23(3):307-18. PubMed ID: 21112032
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma/leukaemias.
Hashimoto M; Yamashita Y; Mori N
J Pathol; 2002 Jul; 197(3):341-7. PubMed ID: 12115880
[TBL] [Abstract][Full Text] [Related]
32. ABL1 rearrangements in T-cell acute lymphoblastic leukemia.
Hagemeijer A; Graux C
Genes Chromosomes Cancer; 2010 Apr; 49(4):299-308. PubMed ID: 20073070
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).
Stark B; Avigad S; Luria D; Manor S; Reshef-Ronen T; Avrahami G; Yaniv I
Pediatr Blood Cancer; 2009 Jan; 52(1):20-5. PubMed ID: 19006253
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic study of 128 cases of T-lymphoblastic lymphoma/leukemia].
Yu B; Du JR; Xie JL; Yu R; Zheng XD; Zhu H; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):452-7. PubMed ID: 21055173
[TBL] [Abstract][Full Text] [Related]
35. [Dynamic analysis of junctional sequences of T cell receptor (TCR) delta and gamma gene rearrangement in childhood with acute lymphoblastic leukemia].
Lu J; Gu R; Lei K; Wang X; Sun L; Pang X; Li X; Dong Z
Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):301-4. PubMed ID: 11876997
[TBL] [Abstract][Full Text] [Related]
36. FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Cohen MH; Johnson JR; Justice R; Pazdur R
Oncologist; 2008 Jun; 13(6):709-14. PubMed ID: 18586926
[TBL] [Abstract][Full Text] [Related]
37. T-cell receptor molecular diagnosis of T-cell lymphoma.
Hodges E; Williams AP; Harris S; Smith JL
Methods Mol Med; 2005; 115():197-215. PubMed ID: 15998969
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous involvement in lymphoblastic lymphoma.
Chimenti S; Fink-Puches R; Peris K; Pescarmona E; Pütz B; Kerl H; Cerroni L
J Cutan Pathol; 1999 Sep; 26(8):379-85. PubMed ID: 10551409
[TBL] [Abstract][Full Text] [Related]
39. Fine needle aspiration of lymphoblastic lymphoma. A multiparameter diagnostic approach.
Jacobs JC; Katz RL; Shabb N; el-Naggar A; Ordonez NG; Pugh W
Acta Cytol; 1992; 36(6):887-94. PubMed ID: 1449027
[TBL] [Abstract][Full Text] [Related]
40. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.
Zhu YM; Zhao WL; Fu JF; Shi JY; Pan Q; Hu J; Gao XD; Chen B; Li JM; Xiong SM; Gu LJ; Tang JY; Liang H; Jiang H; Xue YQ; Shen ZX; Chen Z; Chen SJ
Clin Cancer Res; 2006 May; 12(10):3043-9. PubMed ID: 16707600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
